Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation implanted its PRIMA vision-restoring chip into its first Stargardt disease patient, enabling the patient to see letters and words during rehabilitation. The chip acts as artificial photoreceptors, transmitting visual signals to the brain via the optic nerve.